Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-03

Clinical Trial Update: Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia [Phase 4]

View source ↗

Summary

Phase 4 trial update on bleeding patterns and user satisfaction with a second consecutive use of MIRENA for contraception and treatment of menorrhagia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirena (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Bayer | Conditions: Contraception, Menorrhagia | Phase 4 | Status: COMPLETED